FDA-Drug2026-08-19Class IPROCESSING DEFECT

Baxter Cefazolin in Dextrose injection recalled for particulate matter

Nationwide distributionDrugs

What this means

Baxter Healthcare Corporation is recalling one lot of Cefazolin in Dextrose injection due to the presence of particulate matter in the solution. The affected product is a frozen premix infusion bag used for intravenous antibiotic treatment. This is a Class I recall, the most serious classification.

  • Check your facility's supply for lot #LD175708 (expiration 14-Feb-2027, NDC 0338-3508-41).
  • Do not use affected bags. Quarantine and return them to your supplier or Baxter.
  • Contact Baxter or the FDA if you have questions or have already administered product from this lot.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Presence of Particulate Matter

Intended for
Adults
Illnesses reported
None reported
Sold states
US Nationwide.
Affected count
19,032 bags
Manufactured in
1 Baxter Pkwy, Deerfield, IL, United States
Products
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0787-2026

More Baxter recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.